Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D

被引:176
作者
Stanfield, RL
Gorny, MK
Williams, C
Zolla-Pazner, S
Wilson, IA
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] NYU, Sch Med, New York, NY 10010 USA
[4] Vet Adm Med Ctr, New York, NY 10010 USA
关键词
D O I
10.1016/j.str.2004.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
447-52D is a human monoclonal antibody isolated from a heterohybridoma derived from an HIV-1-infected individual. This antibody recognizes the hypervariable gp120 V3 loop, and neutralizes both X4 and R5 primary isolates, making it one of the most effective anti-V3 antibodies characterized to date. The crystal structure of the 447-52D Fab in complex with a 16-mer V3 peptide at 2.5 Angstrom resolution reveals that the peptide beta hairpin forms a three-stranded mixed beta sheet with complementarity determining region (CDR) H3, with most of the V3 side chains exposed to solvent. Sequence specificity is conferred through interaction of the type-II turn (residues GPGR) at the apex of the V3 hairpin with the base of CDR H3. This novel mode of peptide-antibody recognition enables the antibody to bind to many different V3 sequences where only the GPxR core epitope is absolutely required.
引用
收藏
页码:193 / 204
页数:12
相关论文
共 80 条
  • [1] Standard conformations for the canonical structures of immunoglobulins
    AlLazikani, B
    Lesk, AM
    Chothia, C
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) : 927 - 948
  • [2] Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding
    Basmaciogullari, S
    Babcock, GJ
    Van Ryk, D
    Wojtowicz, W
    Sodroski, J
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (21) : 10791 - 10800
  • [3] Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype
    Bhattacharyya, D
    Brooks, BR
    Callahan, L
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (02) : 83 - 90
  • [4] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [5] A structure-based approach to a synthetic vaccine for HIV-1
    Cabezas, E
    Wang, M
    Parren, PWHI
    Stanfield, RL
    Satterthwait, AC
    [J]. BIOCHEMISTRY, 2000, 39 (47) : 14377 - 14391
  • [6] Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
    Calarese, DA
    Scanlan, CN
    Zwick, MB
    Deechongkit, S
    Mimura, Y
    Kunert, R
    Zhu, P
    Wormald, MR
    Stanfield, RL
    Roux, KH
    Kelly, JW
    Rudd, PM
    Dwek, RA
    Katinger, H
    Burton, DR
    Wilson, IA
    [J]. SCIENCE, 2003, 300 (5628) : 2065 - 2071
  • [7] LOCAL AND GLOBAL STRUCTURAL-PROPERTIES OF THE HIV-MN V3 LOOP
    CATASTI, P
    FONTENOT, JD
    BRADBURY, E
    GUPTA, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (05) : 2224 - 2232
  • [8] Structure and polymorphism of HIV-1 third variable loops
    Catasti, P
    Bradbury, EM
    Gupta, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) : 8236 - 8242
  • [9] SOLUTION CONFORMATIONAL PREFERENCES OF IMMUNOGENIC PEPTIDES DERIVED FROM THE PRINCIPAL NEUTRALIZING DETERMINANT OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
    CHANDRASEKHAR, K
    PROFY, AT
    DYSON, HJ
    [J]. BIOCHEMISTRY, 1991, 30 (38) : 9187 - 9194
  • [10] Analysis of the antigen combining site: Correlations between length and sequence composition of the hypervariable loops and the nature of the antigen
    Collis, AVJ
    Brouwer, AP
    Martin, ACR
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (02) : 337 - 354